Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction
A novel clinical and biomarker scoring system has the potential to identify obstructive coronary artery disease in a wide range of patients, according to proof-of-concept research. Today, most patients suspected of having significant coronary artery stenosis — typically defined as at least 70 percent — undergo a range of often costly tests, such as CT angiography and stress testing, that are not entirely without risk.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063